↓ Skip to main content

Dove Medical Press

Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine…

Overview of attention for article published in Drug Design, Development and Therapy, November 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
49 Mendeley
Title
Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study
Published in
Drug Design, Development and Therapy, November 2016
DOI 10.2147/dddt.s116847
Pubmed ID
Authors

Sang-Hyun Ihm, Hui-Kyung Jeon, Tae-Joon Cha, Taek-Jong Hong, Sang-Hyun Kim, Nae-Hee Lee, Jung Han Yoon, Namsik Yoon, Kyung-Kuk Hwang, Sang-Ho Jo, Ho-Joong Youn

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 12%
Student > Bachelor 6 12%
Student > Doctoral Student 5 10%
Other 4 8%
Researcher 3 6%
Other 10 20%
Unknown 15 31%
Readers by discipline Count As %
Medicine and Dentistry 13 27%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Nursing and Health Professions 4 8%
Neuroscience 3 6%
Agricultural and Biological Sciences 2 4%
Other 6 12%
Unknown 16 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2019.
All research outputs
#8,681,963
of 25,728,855 outputs
Outputs from Drug Design, Development and Therapy
#656
of 2,280 outputs
Outputs of similar age
#119,478
of 318,774 outputs
Outputs of similar age from Drug Design, Development and Therapy
#18
of 48 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,280 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 318,774 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.